CMS is doubling down on its push to build a unified, national digital health infrastructure. The federal government’s interoperability framework is actively reshaping how payers, providers, health systems, and tech platforms share patient data.
While it started as voluntary guidance, this push toward standardized, real-time data exchange has quickly become the benchmark for compliance, reimbursement, and healthcare IT valuations.
For founders in the digital health space, this regulatory shift is changing what buyers look for in an acquisition.
What the Framework Actually Changes
At its core, CMS is forcing healthcare systems to stop hoarding data and start sharing it safely.
Here are the primary shifts driving tech adoption across the industry:
Frictionless patient records: Patients can now use verified digital credentials to access and move their complete medical history between different health systems without administrative headaches.
Real-time data exchange: Platforms are expected to support FHIR-based APIs and active record locators, allowing software tools to talk to one another instantly.
Broader data access: Providers and value-based care organizations can pull clinical and billing data much faster to streamline treatment, payment, and operations.
Stricter security and consent: Clear audit trails, verified credentialing, and HIPAA-compliant consent protocols are non-negotiable for anyone connecting to national health networks.
Why Strategic Buyers Care
In M&A, regulatory changes create clear winners and losers. Strategic acquirers and private equity sponsors are paying close attention to which healthtech platforms are built for this new environment, and which ones are stuck on legacy architecture.
Here is how this impacts healthtech valuations:
Premium multiples for data enablers: Companies that simplify secure data exchange, patient identity verification, and API workflow integration are seeing top-tier strategic interest.
Heavy discounts on legacy tech: Buyers view closed, non-interoperable software as a liability. If an acquirer has to rebuild your data architecture post-closing to meet compliance standards, that cost comes straight off your purchase price.
De-risked due diligence: Platforms that can prove they are fully compliant with federal data standards give buyers confidence, leading to cleaner deals and faster closings.
The Takeaway for Founders
If you run a growth-stage company in care coordination, patient engagement, or health data infrastructure, regulatory alignment is no longer just a legal issue, it is a core valuation driver.
Proving that your platform fits seamlessly into this modern data ecosystem removes major buyer risk and sets you up for a strong exit.
If you are thinking about capital strategy or planning an exit over the next 12 to 24 months, let's connect to discuss how to position your company for maximum value.